142 related articles for article (PubMed ID: 28058100)
1. Non-Mucinous Lepidic Predominant Adenocarcinoma Presenting with Extensive Aerogenous Spread.
Takanashi Y; Tajima S; Tsukui M; Shinmura K; Hayakawa T; Takahashi T; Neyatani H; Funai K
Rare Tumors; 2016 Nov; 8(4):6580. PubMed ID: 28058100
[TBL] [Abstract][Full Text] [Related]
2. Unusual presentation of lepidic adenocarcinoma in a healthy female.
Akhtar Z; Laageide L; Robles J; Winters C; Wall GC; Mallen J; Jawa Z
BMC Pulm Med; 2022 May; 22(1):197. PubMed ID: 35578218
[TBL] [Abstract][Full Text] [Related]
3. Lepidic predominant adenocarcinoma with aerogenous spread of mucin in a young patient -- a case report.
Nguyen E; Hakimi M; Chavoshan B; Stringer W; French SW
Exp Mol Pathol; 2014 Jun; 96(3):400-4. PubMed ID: 24768586
[TBL] [Abstract][Full Text] [Related]
4. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.
Clayton F
Cancer; 1986 Apr; 57(8):1555-64. PubMed ID: 3004694
[TBL] [Abstract][Full Text] [Related]
5. Invasive mucinous adenocarcinoma with lepidic-predominant pattern coexisted with tuberculosis: a case report.
Xu X; Guo Y; Li Q; Yang L; Kang J
Front Med; 2018 Jun; 12(3):330-333. PubMed ID: 28687977
[TBL] [Abstract][Full Text] [Related]
6. [Multicystic presentation of a lepidic mucinous adenocarcinoma].
Beurton A; Gomez E; Mandry D; Champigneulle J; Perez P; Chaouat A; Chabot F
Rev Mal Respir; 2016 Nov; 33(9):812-816. PubMed ID: 27444696
[TBL] [Abstract][Full Text] [Related]
7. Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax.
Aoki A; Hara Y; Okudela K; Ishikawa Y; Doshita K; Hashimoto H; Nakashima K; Horita N; Kobayashi N; Kaneko T
Thorac Cancer; 2020 Nov; 11(11):3407-3408. PubMed ID: 32945109
[TBL] [Abstract][Full Text] [Related]
8. Stromal micropapillary predominant lung adenocarcinoma: A rare histological phenotype with poor prognosis.
Hayakawa T; Tajima S; Tsukui M; Takanashi Y; Neyatani H; Funai K
Respirol Case Rep; 2016 Nov; 4(6):e00203. PubMed ID: 28031838
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
10. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors of Non-Predominant-Lepidic Lung Adenocarcinoma Presenting as Ground Glass Opacity: Results of a Multicenter Study.
Messa F; Siciliani A; Piccioni G; Leonardi B; Ciccone AM; D'Andrilli A; Andreetti C; Menna C; Vanni C; Baccarini AE; Tiracorrendo M; Mancini M; Vecchione A; Nocera A; Calabrese G; Meacci E; Margaritora S; Natale G; Fiorelli A; Venuta F; Rendina EA; Maurizi G; Ibrahim M
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392586
[TBL] [Abstract][Full Text] [Related]
13. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
[TBL] [Abstract][Full Text] [Related]
14. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.
Weichert W; Warth A
Curr Opin Pulm Med; 2014 Jul; 20(4):309-16. PubMed ID: 24811831
[TBL] [Abstract][Full Text] [Related]
15. HRCT features between lepidic-predominant type and other pathological subtypes in early-stage invasive pulmonary adenocarcinoma appearing as a ground-glass nodule.
Zhang P; Li T; Tao X; Jin X; Zhao S
BMC Cancer; 2021 Oct; 21(1):1124. PubMed ID: 34666705
[TBL] [Abstract][Full Text] [Related]
16. [A case of diffuse pneumonic type of mucinous adenocarcinoma treated with reduction surgery].
Yokouchi H; Murata K; Murakami M; Okada K; Ebisui C; Okamura S; Yanagisawa T; Nishigaki T; Owada Y; Katoh R; Makino S; Kinuta M; Tamai M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2396-8. PubMed ID: 23268089
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
18. [CA19-9 Producing Mixed Invasive Mucinous and Non-mucinous Adenocarcinoma;Report of a Case].
Hosaka Y; Nouchi T; Nobusawa S
Kyobu Geka; 2019 Sep; 72(9):716-719. PubMed ID: 31506416
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
Boland JM; Maleszewski JJ; Wampfler JA; Voss JS; Kipp BR; Yang P; Yi ES
Hum Pathol; 2018 Jan; 71():8-19. PubMed ID: 28823574
[TBL] [Abstract][Full Text] [Related]
20. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger KR; Yatabe Y; Beer DG; Powell CA; Riely GJ; Van Schil PE; Garg K; Austin JH; Asamura H; Rusch VW; Hirsch FR; Scagliotti G; Mitsudomi T; Huber RM; Ishikawa Y; Jett J; Sanchez-Cespedes M; Sculier JP; Takahashi T; Tsuboi M; Vansteenkiste J; Wistuba I; Yang PC; Aberle D; Brambilla C; Flieder D; Franklin W; Gazdar A; Gould M; Hasleton P; Henderson D; Johnson B; Johnson D; Kerr K; Kuriyama K; Lee JS; Miller VA; Petersen I; Roggli V; Rosell R; Saijo N; Thunnissen E; Tsao M; Yankelewitz D
J Thorac Oncol; 2011 Feb; 6(2):244-85. PubMed ID: 21252716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
